VOYA Investment Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$989K Sell
41,493
-14,598
-26% -$405K ﹤0.01% 1453
2025
Q4
$1.55M Buy
56,091
+38,925
+227% +$993K ﹤0.01% 1320
2025
Q3
$417K Sell
17,166
-8,722
-34% -$174K ﹤0.01% 1842
2025
Q2
$440K Sell
25,888
-9,229
-26% -$161K ﹤0.01% 1956
2025
Q1
$686K Buy
35,117
+12,102
+53% +$317K ﹤0.01% 1724
2024
Q4
$571K Sell
23,015
-1,728
-7% -$44.1K ﹤0.01% 1882
2024
Q3
$606K Sell
24,743
-19,430
-44% -$502K ﹤0.01% 1898
2024
Q2
$1.03M Buy
44,173
+7,543
+21% +$185K ﹤0.01% 1613
2024
Q1
$1.21M Sell
36,630
-4,677
-11% -$146K ﹤0.01% 1550
2023
Q4
$1.12M Buy
41,307
+941
+2% +$23.4K ﹤0.01% 1627
2023
Q3
$971K Buy
40,366
+751
+2% +$20.1K ﹤0.01% 1652
2023
Q2
$1.26M Sell
39,615
-53,278
-57% -$1.73M ﹤0.01% 1544
2023
Q1
$2.84M Sell
92,893
-90
-0.1% -$3.55K ﹤0.01% 1211
2022
Q4
$3.64M Buy
92,983
+621
+0.7% +$27.8K ﹤0.01% 1090
2022
Q3
$4.4M Buy
92,362
+17,903
+24% +$1.02M 0.01% 1010
2022
Q2
$2.88M Buy
74,459
+14,215
+24% +$565K 0.01% 955
2022
Q1
$3.45M Sell
60,244
-2,393
-4% -$157K 0.01% 945
2021
Q4
$4.99M Sell
62,637
-86,015
-58% -$7.37M 0.01% 844
2021
Q3
$12.9M Buy
148,652
+130,168
+704% +$13.1M 0.03% 487
2021
Q2
$2.38M Buy
18,484
+1,004
+6% +$80K ﹤0.01% 1124
2021
Q1
$1.4M Buy
17,480
+489
+3% +$46.5K ﹤0.01% 1374
2020
Q4
$1.39M Buy
16,991
+5,366
+46% +$264K ﹤0.01% 1318
2020
Q3
$286K Buy
+11,625
New +$288K ﹤0.01% 1973

Other funds holding BEAM

VOYA Investment Management's BEAM Position: Q1 2026 in Review

VOYA Investment Management reduced its Beam Therapeutics (BEAM) stake by 26% in Q1 2026, selling an estimated $405K and leaving 41,493 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

VOYA Investment Management first reported a position in BEAM in Q3 2020 and has held it in 23 quarters since. The position peaked at $12.9M in Q3 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • VOYA Investment Management held 41,493 shares of Beam Therapeutics worth $989K as of Q1 2026.
  • VOYA Investment Management sold 14,598 Beam Therapeutics shares in Q1 2026, an estimated $405K.
  • Beam Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1453 holding.
  • VOYA Investment Management first reported a position in Beam Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • VOYA Investment Management's Beam Therapeutics position peaked at $12.9M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.